Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae

NCT: NCT05853952 · RECRUITING

NCT IDNCT05853952
StatusRECRUITING
Start Date2023-04-24
Completion2026-10-23

Brief Summary

To evaluate whether NESA microcurrents can be used as an effective treatment for various sequelae present in stroke patients, specifically in the treatment of spasticity, balance, pain; and whether it affects quality of life, performance of activities of daily living and quality of sleep.

Frequently Asked Questions

What is Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae?

Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae is a clinical trial registered under NCT05853952. Current status: RECRUITING.

What is the status of NCT05853952?

The current status of NCT05853952 (Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae) is: RECRUITING.

When did Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae start?

Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae started on 2023-04-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑